First malaria map in 40 years shows extent of disease burden

February 25, 2008

The first global malaria risk map to be developed in forty years has highlighted the 2.37 billion people at risk from one of the world's deadliest diseases. The findings of the Malaria Atlas Project (MAP), funded by the Wellcome Trust, also offer hope that eliminating the malaria risk for almost one billion of these people should be achievable.

Over the past two years, researchers from the Kenya Medical Research Institute (KEMRI) and the University of Oxford have been compiling information relating to the presence of mosquitoes carrying the malaria parasites and the likelihood they will infect humans as well as studying medical intelligence sources and nationally reported malaria statistics. They have combined these data to develop a new global map of the disease impact and the populations at risk from Plasmodium falciparum, the most deadly malaria parasite. The P. falciparum species of malaria is thought to kill over one million people each year. The results are published today in the open access journal PLoS Medicine.

According to the map, 2.37 billion people are at risk from P. falciparum, mostly in Africa and south and east Asia. However, almost one billion of these people are in areas where the risk of infection is extremely low.

"We were very surprised to find a significant number of people were facing a much lower risk than was previously thought," says Dr Simon Hay from the University of Oxford. "Of course, this does not mean that malaria is any less of a problem, but it gives us hope that eliminating the disease from certain regions may be achievable using tools as simple and cost-effect as insecticide-treated bed nets."

The MAP team believes that by understanding the relative risk affecting different areas, funding agencies and researchers will be able to focus their efforts more effectively.

"By comparing the geographical distribution of malaria risk against spending in that region, we will able to see how effectively funding is being allocated and adjust as necessary," says Professor Snow, head of the MAP team and the KEMRI-Wellcome Trust Research Programme in Nairobi.

The MAP also highlights potential problems facing countries currently aiming to eliminate malaria. For example, Saudi Arabia is currently providing substantial financial support for the elimination of malaria in its neighbour, Yemen. However, the new research shows how high rates of population inflow from Somalia will pose a continued concern due to the potential reintroduction of the parasite. Similar dilemmas are faced by countries in south east Asia.

In accordance with the Wellcome Trust's philosophy on open access and data sharing, all the data and techniques used in MAP are being made freely-accessible to the public via the project website (, something the researchers believe is essential if malaria is to be tackled. The maps are intended to be dynamic, allowing researchers to update information as more accurate data becomes available or the situation on the ground changes. Sharing information in the public domain will help promote this exchange.

"It's not just about the science of malaria mapping," says Dr Carlos Guerra from the University of Oxford. "It's also about making this work accessible to an audience that covers everyone from undergraduates who have little idea where malaria exists in the world, to donors who should know, in order to allocate appropriate funds to malaria endemic countries. Making data and maps more accessible on the worldwide web is a large part of the MAP's philosophy of getting the science accessed, critiqued and used by a much wider range of users."

Wellcome Trust

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to